Vascular stents are tiny wire mesh tubes placed into blood vessels,
arteries or other hollow structures to open the blockage of vessels.
The process for placement of vascular stent into body is known as
vascular stenting. Vascular stenting is considered as a valuable tool
for applications of non-coronary vasculature. These stents are used
to open narrowed vessels and reduce the chances of chest pain or
heart attack. Most of the stents are made up of metal or plastic mesh
like materials. There are commonly two types of stents namely bare
metal stents and covered stents, also called as stent grafts.
The rising aging population will be a major driving factor for the
global vascular stents market, state the analysts. As per the
findings of the World Health Organization (WHO), in 2000 there were
605 million people aged 65 years or more. The number is projected to
reach 2 billion by 2050. Additionally, technological advancements in
medical devices are anticipated to propel the global market for
vascular stents.
Vascular stents have taken over the conventional surgical methods due
to their advantages such as short recovery time, minimized bleeding,
minimal risk of infection, and low cost. However, manufacturers of
vascular stents are predicted to face the biggest challenge of the
availability of alternative therapies.
The report segments the global vascular stents market on the basis of
region and material. Metal stents, biodegradable polymeric stents,
and standard polymeric stents are the primary types of vascular
stents.
Obtain the Future Market Projections for Vascular Stents at: http://bit.ly/2gJdLoi
By geography, the global vascular stents market is divided into
Europe, Asia Pacific, North America, and Rest of the World.
Currently, North America leads the global market for vascular stents
owing to the rising number of people suffering from cardiovascular
diseases. Europe follows North America to be the second largest
market for vascular stents. The rising preference of surgeons to use
newly introduced vascular stents to treat cardiovascular diseases
will propel the vascular stents market in Europe, predict the
analysts. Increasing government funding in China, India, and
South-East Asia is projected to propel this market in Asia Pacific.
The research evaluates company profiles of leading participants
operating in this market to present a competitive landscape. Some of
the prominent players listed in the report are Cook Medical, InnoCore
Technologies BV, Cordis Corporation, MIV Therapeutics Inc., Boston
Scientific Corporation, Translumina GmbH, Stentys SA, SurModics Inc.,
Xtent Inc., Goodman Co. Ltd., Abbott Laboratories, Biosensors
International Ltd., Reva Medical Inc., MicroPort Scientific Corp.,
Allvivo Vascular Inc., and Medtronic, Inc.
No comments:
Post a Comment